» Home » Research 
Print this pageEmail this page URLConvert this page to PDF

Publications from this research unit

This page shows only publications with IRC as the affiliation of at least one author.
Publications by IRC members mentioning other affiliations are not in our database. Sorry.
See "Extra muros" papers of the units.

For copyright reasons, PDF-versions of our publications are available on the intranet only (login required  ). If you would like to receive a reprint of an IRC paper, please copy/paste the reference in the
reprint request form 


Baraliakos, X, Ostergaard, M, Lambert, RG, Eshed, I, Machado, PM, Pedersen, SJ, Weber, U, de Hooge, M, Sieper, J, Poddubnyy, D, Rudwaleit, M, van der Heijde, D, Landewe, RB, Maksymowych, WP.
MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group
Ann Rheum Dis , in press, 2022. (Epub 2022 May 24)

Beterams, A, Calatayud Arroyo, M, De Paepe, K, De Craemer, AS, Elewaut, D, Venken, K, Van de Wiele, T.
In vitro triple coculture with gut microbiota from spondyloarthritis patients is characterized by inter-individual differences in inflammatory responses
Sci Rep 12, 10475, 2022. (Epub 2022 Jun 21)

Ciurea, A, Kissling, S, Burki, K, Baraliakos, X, de Hooge, M, Hebeisen, M, Papagiannoulis, E, Exer, P, Bram, R, Nissen, MJ, Moller, B, Kyburz, D, Andor, M, Distler, O, Scherer, A, Micheroli, R.
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort
RMD Open 8, e002067, 2022. (Epub 2022 Feb 2)

Costantino, F, Aegerter, P, Schett, G, De Craemer, AS, Molto, A, Van den Bosch, F, Elewaut, D, Breban, M, D'Agostino, MA.
Cluster analysis in early axial spondyloarthritis predicts poor outcome in the presence of peripheral articular manifestations
Rheumatology (Oxford) 61, 32893298, 2022. (Epub 2021 Dec 3)

D'Agostino, MA, Schett, G, Lopez-Rdz, A, Senolt, L, Fazekas, K, Burgos-Vargas, R, Maldonado-Cocco, J, Naredo, E, Carron, P, Duggan, AM, Goyanka, P, Boers, M, Gaillez, C.
Response to Secukinumab on Synovitis using Power Doppler Ultrasound in Psoriatic Arthritis: 12-week Results from a Phase III Study, ULTIMATE
Rheumatology (Oxford) 61, 1867-1876, 2022. (Epub 2021 Sep 16)

De Craemer, AS, Deroo, L, Renson, T, Desimpele, I, Delmez, L, Decuman, S, Janssens, X, Boonen, A, Elewaut, D, Carron, P, Van den Bosch, F.
Work participation is unaffected in Belgian spondyloarthritis patients: data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT
Rheumatology (Oxford) , in press, 2022. (Epub 2022 Sep 13)

De Craemer, AS, Renson, T, Deroo, L, Van Praet, L, Cypers, H, Varkas, G, Joos, R, Devinck, M, Gyselbrecht, L, Peene, I, Thevissen, K, Costantino, F, D'Agostino, MA, Lenaerts, J, Carron, P, Van den Bosch, F, Elewaut, D.
Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritis
Rheumatology (Oxford) 61, 32793288, 2022. (Epub 2021 Nov 30)

De Craemer, AS, Witte, T, Lobaton Ortega, T, Hoorens, A, De Vos, M, Cuvelier, C, Vastert, SJ, Baraliakos, X, Van den Bosch, F, Elewaut, D.
Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation
Rheumatology (Oxford) , in press, 2022. (Epub 2022 Jul 4)

Deodhar, A, Van den Bosch, F, Poddubnyy, D, Maksymowych, WP, van der Heijde, D, Kim, TH, Kishimoto, M, Blanco, R, Duan, Y, Li, Y, Pangan, AL, Wung, P, Song, IH.
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet 400, 369-379, 2022. (Epub 2022 Jul 30)

Deodhar, A, van der Heijde, D, Sieper, J, Van den Bosch, F, Maksymowych, WP, Kim, TH, Kishimoto, M, Ostor, A, Combe, B, Sui, Y, Chu, AD, Song, IH.
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension
Arthritis Rheumatol 74, 70-80, 2022. (Epub 2021 Jul 1)

De Ponti, FF, Scott, CL.
A breath of fresh macrophages ameliorates inflammation in the hypoxic lung
Nat Immunol 23, 820-822, 2022. (Epub 2022 May 26)

Deprez, J, Roovers, S, Lajoinie, G, Dewitte, H, Decruy, T, Coudenys, J, Descamps, B, Vanhove, C, Versluis, M, Elewaut, D, Jacques, P, De Smedt, SC, Lentacker, I.
Evaluation of Liposome-Loaded Microbubbles as a Theranostic Tool in a Murine Collagen-Induced Arthritis Model
Scientia Pharmaceutica 90, 17, 2022. (Epub 2022 Feb 28)

de Reuver, R, Verdonck, S, Dierick, E, Nemegeer, J, Hessmann, E, Ahmad, S, Jans, M, Blancke, G, Van Nieuwerburgh, F, Botzki, A, Vereecke, L, van Loo, G, Declercq, W, Hur, S, Vandenabeele, P, Maelfait, J.
ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation
Nature 607, 784-789, 2022. (Epub 2022 Jul 20)

Deroo, L, Achten, H, De Boeck, K, Genbrugge, E, Bauters, W, Roels, D, Dochy, F, Creytens, D, De Craemer, AS, Van den Bosch, F, Elewaut, D, Peene, I.
Discriminative power of salivary gland ultrasound in relation to symptom-based endotypes in suspected and definite primary Sjogren's Syndrome
Semin Arthritis Rheum 56, 152075, 2022. (Epub 2022 Jul 22)

De Spiegeleer, A, Van Migerode, J, Bronselaer, A, Wynendaele, E, Peelman, M, Vandaele, F, Byttebier, G, De Tre, G, Belmans, L, Van De Wiele, C, Sathekge, M, Van Dijck, D, Saxberg, B, Alexander, M, Fedson, D, Elewaut, D, Van Den Noortgate, N, De Spiegeleer, B.
Statin Intake and All-Cause Mortality among Older Nursing Home Residents
Gerontology 68, 407411, 2022. (Epub 2021 Jun 16)

De Spiegeleer, A, Wynendaele, E, Descamps, A, Debunne, N, Braeckman, BP, De Mey, M, Coudenys, J, Crombez, L, Verbeke, F, Janssens, Y, Janky, R, Goossens, E, Vlaeminck, C, Duchi, D, Andries, V, Dumas, E, Petrovic, M, Van de Wiele, T, Knappe, D, et al..
The bacterial quorum sensing peptide iAM373 is a novel inducer of sarcopenia
Clin Transl Med 12, e1053, 2022. (Epub 2022 Oct 13)

de Vlam, K, Toukap, AN, Kaiser, MJ, Vanhoof, J, Remans, P, Van den Berghe, M, Di Romana, S, Van den Bosch, F, Lories, R.
Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO Study
Adv Ther 39, 1055-1067, 2022. (Epub 2022 Jan 3)

Kiltz, U, Boonen, A, van der Heijde, D, Bautista-Molano, W, Vargas, RB, Chiowchanwisawakit, P, El-Zorkany, B, Gaydukova, I, Geher, P, Gossec, L, Gilio, M, Grazio, S, Gu, J, Khan, MA, Kim, TJ, Maksymowych, WP, Marzo-Ortega, H, Navarro-Compan, V, Ozgocmen, S, et al..
Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial Spondyloarthritis
Rheumatology (Oxford) 61, 2054-2062, 2022. (Epub 2021 Sep 17)

Landewe, RBM, Poddubnyy, D, Rahman, P, Van den Bosch, FE, Bolce, R, Liu Leage, S, Lisse, JR, Park, SY, Gensler, L.
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study
Ann Rheum Dis , in press, 2022. (Epub 2022 Sep 13)

Maksymowych, WP, Lambert, RGW, Caplan, L, van den Bosch, FE, Ostergaard, M.
Improving the design of RCTs in non-radiographic axial spondyloarthritis
Nat Rev Rheumatol 18, 481-489, 2022. (Epub 2022 May 13)

Maschalidi, S, Mehrotra, P, Keceli, BN, De Cleene, HKL, Lecomte, K, Van der Cruyssen, R, Janssen, P, Pinney, J, van Loo, G, Elewaut, D, Massie, A, Hoste, E, Ravichandran, KS.
Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes
Nature 606, 776784, 2022. (Epub 2022 May 25)

Ostor, A, Van den Bosch, F, Papp, K, Asnal, C, Blanco, R, Aelion, J, Alperovich, G, Lu, W, Wang, Z, Soliman, AM, Eldred, A, Barcomb, L, Kivitz, A.
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
Ann Rheum Dis 81, 351-358, 2022. (Epub 2021 Nov 23)

Palomares, O, Elewaut, D, Irving, PM, Jaumont, X, Tassinari, P.
Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity?
Allergy , in press, 2022. (Epub 2022 Jul 19)

Renson, T, de Hooge, M, De Craemer, AS, Deroo, L, Lukasik, Z, Carron, P, Herregods, N, Jans, L, Colman, R, Van den Bosch, F, Elewaut, D.
Progressive increase in sacroiliac joint and spinal mri lesions in healthy individuals in relation to age
Arthritis Rheumatol 74, 1506-1514, 2022. (Epub 2022 Apr 18)

Renson, T, Van den Bosch, FE, Elewaut, D.
Response to: 'Finding the right one' by Zanwar
Ann Rheum Dis 81, e88, 2022. (Epub 2020 May 28)

Reuter, K, Haupt, C, Molto, A, Cope, A, van Vollenhoven, RF, Elewaut, D, Lories, R, McInnes, IB.
Levelling the playing field of RMD research across Europe to address patients' needs: the emerging EULAR Research Centre
RMD Open 8, e002456, 2022. (Epub 2022 Jun 17)

Rigauts, C, Aizawa, J, Taylor, S, Rogers, GB, Govaerts, M, Cos, P, Ostyn, L, Sims, S, Vandeplassche, E, Sze, M, Dondelinger, Y, Vereecke, L, Van Acker, H, Simpson, JL, Burr, L, Willems, A, Tunney, MM, Cigana, C, Bragonzi, A, et al..
Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease
Eur Respir J 59, 2101293, 2022. (Epub 2021 Sep 29)

Schett, G, Rahman, P, Ritchlin, C, McInnes, IB, Elewaut, D, Scher, JU.
Psoriatic arthritis from a mechanistic perspective
Nat Rev Rheumatol 18, 311-325, 2022. (Epub 2022 May 5)

Shirakashi, M, Maruya, M, Hirota, K, Tsuruyama, T, Matsuo, T, Watanabe, R, Murata, K, Tanaka, M, Ito, H, Yoshifuji, H, Ohmura, K, Elewaut, D, Sakaguchi, S, Fagarasan, S, Mimori, T, Hashimoto, M.
Effect of Impaired T Cell Receptor Signaling on the Gut Microbiota in a Mouse Model of Systemic Autoimmunity
Arthritis Rheumatol 74, 641-653, 2022. (Epub 2021 Nov 1)

So, J, De Craemer, AS, Elewaut, D, Tam, LS.
Spondyloarthritis: How far are we from precision medicine?
Front Med (Lausanne) 9, 988532, 2022. (Epub 2022 Sep 8)

Trickey, J, Sahbudin, I, Ammitzboll-Danielsen, M, Azzolin, I, Borst, C, Bortoluzzi, A, Bruyn, GA, Carron, P, Ciurtin, C, Filippou, G, Flicinski, J, Fodor, D, Gouze, H, Gutierrez, M, Hammer, HB, Hauge, EM, Iagnocco, A, Ikeda, K, Karalilova, R, et al..
Very low prevalence of ultrasound-detected tenosynovial abnormalities in healthy subjects throughout the age range: OMERACT ultrasound minimal disease study
Ann Rheum Dis 81, 232-236, 2022. (Epub 2021 Aug 18)

van der Heijde, D, Deodhar, A, Maksymowych, WP, Sieper, J, Van den Bosch, F, Kim, TH, Kishimoto, M, Ostor, AJ, Combe, B, Sui, Y, Duan, Y, Wung, PK, Song, IH.
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
RMD Open 8, e002280, 2022. (Epub 2022 Jul 27)

Van Hoovels, L, Studholme, L, Vander Cruyssen, B, Sieghart, D, Bonroy, C, Nagy, E, Pullerits, R, Cucnik, S, Dahle, C, Heijnen, I, Bernasconi, L, Benkhadra, F, Bogaert, L, Van Den Bremt, S, Van Liedekerke, A, Vanheule, G, Robbrecht, J, Wirth, C, Muller, R, et al..
Standardisation of ACPA tests: evaluation of a new candidate reference preparation
Ann Rheum Dis , in press, 2022. (Epub 2022 Jun 13)

Van Hoovels, L, Vander Cruyssen, B, Sieghart, D, Bonroy, C, Nagy, E, Pullerits, R, Cucnik, S, Dahle, C, Heijnen, I, Bernasconi, L, Benkhadra, F, Bogaert, L, Van Den Bremt, S, Van Liedekerke, A, Vanheule, G, Robbrecht, J, Studholme, L, Wirth, C, Muller, R, et al..
IgA rheumatoid factor in rheumatoid arthritis
Clin Chem Lab Med 60, 1617-1626, 2022. (Epub 2022 Jul 6)

Van Hoovels, L, Vander Cruyssen, B, Sieghart, D, Bonroy, C, Nagy, E, Pullerits, R, Cucnik, S, Dahle, C, Heijnen, I, Bernasconi, L, Benkhadra, F, Bogaert, L, Van Den Bremt, S, Van Liedekerke, A, Vanheule, G, Robbrecht, J, Studholme, L, Wirth, C, Muller, R, et al..
Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results
RMD Open 8, e002099, 2022. (Epub 2022 Mar)

Villar, VH, Allega, MF, Deshmukh, R, Ackermann, T, Nakasone, MA, Vande Voorde, J, Drake, TM, Oetjen, J, Bloom, A, Nixon, C, Muller, M, May, S, Tan, EH, Vereecke, L, Jans, M, Blancke, G, Murphy, DJ, Huang, DT, Lewis, DY, et al..
Hepatic glutamine synthetase controls N(5)-methylglutamine in homeostasis and cancer
Nat Chem Biol , in press, 2022. (Epub 2022 Oct 24)

Wynendaele, E, Debunne, N, Janssens, Y, De Spiegeleer, A, Verbeke, F, Tack, L, Van Welden, S, Goossens, E, Knappe, D, Hoffmann, R, Van De Wiele, C, Laukens, D, Van Eenoo, P, Vereecke, L, Van Immerseel, F, De Wever, O, De Spiegeleer, B.
The quorum sensing peptide EntF* promotes colorectal cancer metastasis in mice: a new factor in the host-microbiome interaction
BMC Biol 20, 151, 2022. (Epub 2022 Jun 27)

Arandjelovic, S, Perry, JSA, Zhou, M, Ceroi, A, Smirnov, I, Walk, SF, Shankman, LS, Cambre, I, Onengut-Gumuscu, S, Elewaut, D, Conrads, TP, Ravichandran, KS.
ELMO1 signaling is a promoter of osteoclast function and bone loss
Nat Commun 12, 4974, 2021. (Epub 2021 Aug 17)

Baraliakos, X, Van den Bosch, F, Machado, PM, Gensler, LS, Marzo-Ortega, H, Sherif, B, Quebe-Fehling, E, Porter, B, Gaillez, C, Deodhar, A.
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
Rheumatol Ther 8, 273-288, 2021. (Epub 2020 Dec 22)

Behrens, F, Leage, SL, Sapin, C, Baou, CE, De La Torre, I, Meszaros, G, Schett, G, Combe, B, van den Bosch, F, Gossec, L.
Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52
Clin Rheumatol 40, 4943-4954, 2021. (Epub 2021 Sep 13)

Borras-Tuduri, R, Alcaide, A, Aspeslag, S, Usero, L, Serra, C, Roura-Mir, C, Elewaut, D, Llebaria, A.
New paradigm in NKT cell antigens: MCS-0208 (2-(Hydroxymethyl)phenylthio-phytoceramide) an aryl-phytoceramide compound with a single hydroxyl group stimulates NKT cells
ChemMedChem 16, 2491-2496, 2021. (Epub 2021 Apr 6)

Braun, J, Blanco, R, Marzo-Ortega, H, Gensler, LS, van den Bosch, F, Hall, S, Kameda, H, Poddubnyy, D, van de Sande, M, Wiksten, AS, Porter, BO, Shete, A, Richards, HB, Haemmerle, S, Deodhar, A.
Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT
Arthritis Res Ther 23, 231, 2021. (Epub 2021 Sep 4)

Carron, P, De Craemer, AS, Renson, T, Colman, R, Elewaut, D, Van den Bosch, F.
TNFi-induced sustained clinical remission in peripheral spondyloarthritis patients cannot be maintained with a step-down strategy based on methotrexate
Rheumatology (Oxford) 60, 4880-4883, 2021. (Epub 2021 Oct 21)

De Mits, S, De Craemer, AS, Deroo, L, Renson, T, Van den Bosch, FE, Carron, P, Elewaut, D.
Unexpected impact of COVID-19 lockdown on spinal mobility and health perception in spondyloarthritis
Ann Rheum Dis 80, 1638-1640, 2021. (Epub 2021 Jun 29)

De Spiegeleer, A, Kahya, H, Sanchez-Rodriguez, D, Piotrowicz, K, Surquin, M, Marco, E, Detremerie, C, Hussein, D, Hope, S, Dallmeier, D, Decker, G, Hrnciarikova, D, Czesak, J, Toscano-Rico, M, Meza-Valderrama, D, Bahat, G, Descamps, A, Wynendaele, E, Elewaut, D, et al..
Acute sarcopenia changes following hospitalization: influence of pre-admission care dependency level
Age Ageing 50, 2140-2146, 2021. (Epub 2021 Aug 9)

de Vlam, K, Steinfeld, S, Toukap, AN, van den Bosch, F, Joos, R, Geussens, P, Leroi, H, Lories, R, Investigators, BS.
The burden of psoriatic arthritis in the biological era: data from the Belgian Epidemiological Psoriatic Arthritis Study (BEPAS)
Rheumatology (Oxford) 60, 5677-5685, 2021. (Epub 2021 Mar 12)

Elewaut, D, Braun, J, Anderson, JK, Arikan, D, Chen, S, Hojnik, M, De Craemer, AS, Curtis, JR.
Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases
Arthritis Care Res (Hoboken) 73, 289295, 2021. (Epub 2020 Feb 26)

Fleischmann, RM, Blanco, R, Hall, S, Thomson, GTD, Van den Bosch, FE, Zerbini, C, Bessette, L, Enejosa, J, Li, Y, Song, Y, DeMasi, R, Song, IH.
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis
Ann Rheum Dis 80, 432-439, 2021. (Epub 2020 Nov 4)

Guggino, G, Mauro, D, Rizzo, A, Alessandro, R, Raimondo, S, Bergot, AS, Rahman, MA, Ellis, JJ, Milling, S, Lories, R, Elewaut, D, Brown, MA, Thomas, R, Ciccia, F.
Inflammasome activation in Ankylosing Spondylitis is associated to gut dysbiosis
Arthritis Rheumatol 73, 1189-1199, 2021. (Epub 2021 Jan 16)

Hromadova, D, Elewaut, D, Inman, RD, Strobl, B, Gracey, E.
From Science to Success? Targeting Tyrosine Kinase 2 in Spondyloarthritis and Related Chronic Inflammatory Diseases
Front Genet 12, 685280, 2021. (Epub 2021 Jul 5)

Back to previous page

Export in CSV

Page 1 of 5
<< 1 - 2 - 3 - 4 - 5 >>

To top

What do these icons mean?

pdf file (800 kb)